Mid Atlantic Retina
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Mid Atlantic Retina sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Mid Atlantic Retina: 6 sponsored US clinical trials, none currently recruiting.
Mid Atlantic Retina sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Aged Macular Degeneration, with 1 trials.
Upper-quartile sponsor footprint
Mid Atlantic Retina sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope
NCT03075852
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
NCT01773954
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
NCT01255293
Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.
NCT01809093
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
NCT01257698
Omega-3-fatty Acids on Age-related Macular
NCT01258335
Therapeutic Areas
How the Mid Atlantic Retina archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Aged Macular Degeneration (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Mid Atlantic Retina: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Mid Atlantic Retina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Mid Atlantic Retina page
6 registered trials is a research-attention snapshot, not an endorsement of Mid Atlantic Retina or any single study.
- None of Mid Atlantic Retina's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Aged Macular Degeneration is the condition Mid Atlantic Retina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aged Macular Degeneration trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mid Atlantic Retina pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.